Redeye comments on IRRAS’ directed share issue. While the SEK 66m injection adds length to its financial runway, we are more interested in the share’s prospects of regaining confidence from the investors, which the raise could help accomplish. Furthermore, we adjust our Fair Value Range owing to the new number of shares and increased cash position.